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Next generation sequencing (NGS), using massive paral-
lel sequencing, is increasingly being used in the clinical
setting. It is a high throughput technique that offers a
fast and cost-effective testing solution for genetic disor-
ders with a number of candidate genes.
In this study we have employed NGS to sequence 48
samples that had been referred to the Molecular Genet-
ics Department for the investigation of Monogenic Dis-
orders of Insulin Secretion (MDOIS), Disorders of
Sexual Development (DSD) and Noonan Syndrome
(NS). All samples had previously been genotyped using
Sanger sequencing.
Next Generation Sequencing was performed on an Illu-
mina MiSeq using an Illumina Nextera Rapid Capture
Custom Enrichment Kit. This custom assay contained
capture probes for the coding regions (including +/- 5
bases of intronic sequence) for 66 genes: 34 for DSD; 19
for MDOIS; and 13 for NS. Sequence data generated by
the MiSeq was aligned to hg19 and variants detected
using CLC Genomics Workbench. Genetic variants were
annotated using Cartagenia BENCHlab NGS.
Thirty mutations associated with DSD (SRD5A2,
HSD17B3, NR5A1, AR), MDOIS (ABCC8, GCK, GLUD1,
INS, HNF1A, HNF4A, HNF1B) and NS (PTPN11, RAF1)
were detected. This was concordant with genotypes
detected by Sanger sequencing.
Next generation sequencing has proven to be an accu-
rate and efficient method of genotyping monogenic dis-
orders with multiple candidate genes, and is an ideal
technique for the clinical laboratory.
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